Lundbeck buys rights for Alzheimer's treatment - Forbes by Alzheimers treatment

Wed, 04 Jun 2008 01:36:09 -0400

Lundbeck buys rights for Alzheimer's treatment - Forbes

by Alzheimers treatment @ Wed, 04 Jun 2008 01:36:09 -0400

Lundbeck buys rights for Alzheimer's treatment
Forbes, NY -May 22, 2008
... it has acquired the European commercialisation rights for Flurizan, a phase III drug candidate that may have the potential to treat Alzheimer's disease, ...
Myriad Genetics Sells Flurizan RightsTheStreet.com
Myriad Genetics Selects Lundbeck as European Partner for FlurizanCNNMoney.com
Lundbeck: Myriad Deal is a High Risk High Reward StrategyRedOrbit
Pharma Times (subscription) - BioWorld Online
all 43 news articles